New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 22, 2024 - The FDA approved Shorla Oncology’s Imkeldi (imatinib) oral solution.
Download PDF
Return to publications
